ORIC FY 2022 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$92M

Net Income

-$89M

EPS (Diluted)

$-2.25

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$77M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$250M

Total Liabilities

$28M

Stockholders' Equity

$222M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$92M	-$79M	-16.4%
Net Income	-$89M	-$79M	-13.2%